检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

OAB-012: Early and sustained negative minimal residual disease (MRDneg) after idecabtagene vicleucel (ide-cel) defines a subset of multiple myeloma (MM) patients in KarMMa achieving prolonged survival

Bruno Paiva,Irene Manrique,Julie Rytlewski,Timothy Campbell, Christian Kazanecki,Nathan Martin,Shari Kaiser,Larry Anderson,Jesus G. Berdeja,Sagar Lonial,Noopur Raje,Yi Lin,Philippe Moreau,Jesus San-Miguel,Nikhil Munshi

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览12
暂无评分
关键词
multiple myeloma,negative minimal residual disease,karmma,mrdneg,ide-cel
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要